Carret Asset Management LLC Sells 120 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Carret Asset Management LLC lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,813 shares of the financial services provider’s stock after selling 120 shares during the period. Carret Asset Management LLC’s holdings in iShares Biotechnology ETF were worth $386,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. increased its holdings in shares of iShares Biotechnology ETF by 5.5% in the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after buying an additional 115 shares during the period. Pinnacle Wealth Management Advisory Group LLC increased its holdings in shares of iShares Biotechnology ETF by 8.3% in the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock worth $262,000 after buying an additional 148 shares during the period. Corient Private Wealth LLC increased its holdings in shares of iShares Biotechnology ETF by 1.0% in the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after buying an additional 841 shares during the period. Great Valley Advisor Group Inc. increased its holdings in iShares Biotechnology ETF by 14.1% during the 4th quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock valued at $378,000 after purchasing an additional 344 shares during the period. Finally, Premier Path Wealth Partners LLC purchased a new position in iShares Biotechnology ETF during the 4th quarter valued at about $207,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ:IBB opened at $135.09 on Thursday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The stock’s 50-day moving average is $134.94 and its 200 day moving average is $134.97.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.